MKI67 and breast cancer: Patients with Luminal B-like BC had an approximate twofold risk of developing distant disease (HR = 1.91; 95% CI 1.35–2.71; P = 0.0003) than patients with Luminal A-like BC defined using Ki-67 (30-9).